Stay updated on Acetylsalicylic Acid in Aneurysm Patients Clinical Trial
Sign up to get notified when there's something new on the Acetylsalicylic Acid in Aneurysm Patients Clinical Trial page.

Latest updates to the Acetylsalicylic Acid in Aneurysm Patients Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe clinical trial record for PROTECT-U is displayed, including its study design, eligibility criteria, interventions, outcomes, and participating locations, in place of a forbidden-access error page.SummaryDifference87%

- Check19 days agoChange DetectedThe footer now identifies the site as revision v3.8.0 instead of v3.7.2. The study record still displays a 403 Forbidden error.SummaryDifference0.2%

- Check26 days agoChange DetectedA site-wide banner announces NIH website updates and says the agency is transitioning from the term “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check33 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check40 days agoChange DetectedThe site revision identifier in the page footer changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check60 days agoChange DetectedThe page now displays a 403 error (with minimal HTML structure and a Home link) instead of the expected study record content, signaling a access problem rather than an actual data update.SummaryDifference20%

Stay in the know with updates to Acetylsalicylic Acid in Aneurysm Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Acetylsalicylic Acid in Aneurysm Patients Clinical Trial page.